首页 | 本学科首页   官方微博 | 高级检索  
检索        


Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology
Institution:1. Department of Pathology and Laboratory Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas, United States of America;2. Cell & Molecular Biology | Luda Hill Department of Bioinformatics, University of Texas, Southwestern Medical Center, Dallas, Texas, United States of America;3. Department of Oncology, The First Hospital of Dalian Medical University, Dalian, China;4. Division of Medical Technology Development, Hangzhou Zhiwei Information & Technology Ltd., Hangzhou, China;1. NewYork-Presbyterian Hospital, Weill Cornell Campus, United States of America;2. Weill Cornell Medicine, United States of America
Abstract:Digital pathology has a crucial role in diagnostic pathology and is increasingly a technological requirement in the field. Integration of digital slides into the pathology workflow, advanced algorithms, and computer-aided diagnostic techniques extend the frontiers of the pathologist's view beyond the microscopic slide and enable true integration of knowledge and expertise. There is clear potential for artificial intelligence (AI) breakthroughs in pathology and hematopathology.In this review article, we discuss the approach of using machine learning in the diagnosis, classification, and treatment guidelines of hematolymphoid disease, as well as recent progress of artificial intelligence in flow cytometric analysis of hematolymphoid diseases. We review these topics specifically through the potential clinical applications of CellaVision, an automated digital image analyzer of peripheral blood, and Morphogo, a novel artificial intelligence-based bone marrow analyzing system. Adoption of these new technologies will allow pathologists to streamline workflow and achieve faster turnaround time in diagnosing hematological disease.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号